Cargando…

1796 Recovery of Clostridium difficile, Vancomycin Resistant Enterococcus and Methicillin Resistant Staphylococcus aureus from the Food of Hospitalized Patients

Detalles Bibliográficos
Autores principales:	Kwon, Jennie H., Bommarito, Kerry M., Reske, Kimberly, Hink, Tiffany, Seiler, Sondra, Wallace, Meghan, Burnham, Carey-Ann D., Dubberke, Erik R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	IDWeek 2014 Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781828/ http://dx.doi.org/10.1093/ofid/ofu051.168

Ejemplares similares

Etiology of Infectious Diarrhea in Patients Tested for Clostridium difficile: If It Isn’t Clostridium difficile, What Is It?
por: Kwon, Jennie H, et al.
Publicado: (2017)

1647 Are Hospital Floors an Underappreciated Reservoir for Transmission of Clostridium difficile and Methicillin-Resistant Staphylococcus aureus?
por: Deshpande, Abhishek, et al.
Publicado: (2014)

307 Prevalence of qac A/B among Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates Recovered from Active Surveillance Cultures of the Anterior Nares in the Setting of Chlorhexidine Bathing
por: Prager, Martin, et al.
Publicado: (2014)

Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients
por: Fishbein, Skye R. S., et al.
Publicado: (2021)

733 Vancomycin-Resistant Enterococcus (VRE) faecium Bloodstream Infections and Mortality
por: Suleyman, Geehan, et al.
Publicado: (2014)

2570. A Randomized Controlled Trial of Lactobacillus rhamnosus GG on Multidrug-Resistant Organism (MDRO) Colonization
por: Rauseo, Adriana M, et al.
Publicado: (2019)

893 Vancomycin Resistant Enterococcus (VRE) Rates in Ontario, Canada After the Discontinuation of VRE Screening and Control Practices by Some Hospitals: Interim Results
por: Lam, Freda, et al.
Publicado: (2014)

288 Lack of Synergy With Six Blood Isolates of Methicillin-Resistant Staphylococcus aureus (Vancomycin MIC of 2) Tested With Combinations of Vancomycin + Gentamicin, Vancomycin + Rifampin and Vancomycin + Cefazolin.
por: Long, Virginia, et al.
Publicado: (2014)

902 Hospital Characteristics and Infection Prevention and Control Strategies Associated with Methicillin-Resistant Staphylococcus aureus (MRSA) and Clostridium difficile Infection (CDI) in Canadian Hospitals
por: Williams, Victoria, et al.
Publicado: (2014)

833 Lactobacillus GG (LGG) Does Not Eliminate Colonization by Vancomycin Resistant Enterococcus (VRE) in Adults with Comorbidities
por: Doron, Shira, et al.
Publicado: (2014)

115 Comparison of Emerging Infections Program (EIP) and National Healthcare Safety Network (NHSN) Datasets for Surveillance of Methicillin-Resistant Staphylococcus aureus (MRSA) and Clostridium difficile Infection (CDI)
por: Phipps, Erin C., et al.
Publicado: (2014)

192 Vancomycin Dosing in Obese and Morbidly Obese Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia
por: Morrill, Haley, et al.
Publicado: (2014)

395 Impact of vancomycin pharmacokinetic/pharmacodynamic data on clinical outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children
por: Yoo, Reenar, et al.
Publicado: (2014)

1646 Evidence of hospital-associated Clostridium difficile transmission between patients with asymptomatic carriage and patients with Clostridium difficile infection
por: Galdys, Alison, et al.
Publicado: (2014)

721 Decreasing Prevalence of Vancomycin-Heteroresistance (hVISA) among Methicillin-Resistant Staphylococcus aureus (MRSA) Blood Isolates over 10 years: Potential Impact of Vancomycin Treatment Guidelines
por: Khatib, Riad, et al.
Publicado: (2014)

1624 Risk Factors for Hospital-Acquired Clostridium difficile
por: Knepper, Bryan, et al.
Publicado: (2014)

525 Epidemiology and burden of recurrent Clostridium difficile infections
por: Sheitoyan-Pesant, Caroline, et al.
Publicado: (2014)

408 The Comparison of in-vitro Activity of Daptomycin with Vancomycin and Teicoplanin against Methicillin-Resistant Staphylococcus aureus Strains Isolated from Bloodstream Infections
por: Demirdal, Tuna, et al.
Publicado: (2014)

397 Correlation between calculated vancomycin AUC(0-24)/MIC and acute kidney injury in patients with Methicillin Resistant Staphylococcus Aureus bacteraemia
por: Ghosh, Niladri, et al.
Publicado: (2014)

1652 Retrospective Comparision of Oral Vancomycin Capsules vs Oral Vancomycin Solution for the Treatment of Severe Clostridium Defficile Infection
por: Saleh, Rania, et al.
Publicado: (2014)

71 Alterations in the Gut Microbiome in Recurrent Clostridium difficile Infection
por: Wang, Gary, et al.
Publicado: (2014)

1628 Accuracy of Healthcare Facility-Onset Clostridium difficile Classification
por: Trappler, Regan, et al.
Publicado: (2014)

1634 Clinical Characteristics of Relapses AND Reinfections in Clostridium difficile Infection
por: Kim, Jieun, et al.
Publicado: (2014)

1626 The relationship of Bristol Stool Scale to Clostridium difficile infection
por: Caroff, Daniel, et al.
Publicado: (2014)

1651 Role of Metronidazole vs Vancomycin as Initial Therapy in Hospitalized Patients with Mild to Moderate Clostridium difficile Infection (CDI) with NAP1 vs non-NAP1 Disease
por: Dubrovskaya, Yanina, et al.
Publicado: (2014)

1642 Identifying Targets for Prevention Through Clostridium difficile Population Surveillance
por: Dumyati, Ghinwa, et al.
Publicado: (2014)

1649 Acquisition of Clostridium difficile Associated with Potentially Contaminated Inpatient Rooms
por: Williams, Catherine, et al.
Publicado: (2014)

1673 Microbial and Inflammatory Markers for Fatal Clostridium difficile Associated Diarrhea
por: Jiang, Zhi-Dong, et al.
Publicado: (2014)

1620 Extraintestinal Clostridium difficile infections: A Single Center Experience
por: Gupta, Arjun, et al.
Publicado: (2014)

1644 Risk Factors for Community-Associated Clostridium difficile Infection in Children
por: Crews, Jonathan, et al.
Publicado: (2014)

1660 Risk of Recurrent Clostridium difficile Infection: Impact of Diagnostics and Treatment
por: Reddy, Sujan C., et al.
Publicado: (2014)

Concomitant Vancomycin-Resistant Enterococcus faecium and Clostridium difficile Colitis
por: Mehershahi, Shehriyar, et al.
Publicado: (2021)

1798 Oral, Frozen Fecal Microbiota Capsules for Relapsing Clostridium difficile Infection
por: Youngster, Ilan, et al.
Publicado: (2014)

467 Analysis of Clinical and Economical Outcomes of Fidaxomicin Use for Clostridium difficile infections
por: Flaherty, Sarah, et al.
Publicado: (2014)

2322: The effects of fecal microbiota transplantation on the gut microbiota in subjects with Clostridium difficile infection
por: Elizabeth Langdon, Amy, et al.
Publicado: (2018)

280 Association between acessory gene regulator II expression and mortality among critically ill patients receiving vancomycin for hospital-acquired methicillin-resistant Staphylococcus aureus bacteremia
por: Rosa, Regis, et al.
Publicado: (2014)

1657 Who Seeks a Fecal Microbiota Transplant for Recurrent C. difficile Infection?: Patient Profile of the PUNCH CD Study
por: Orenstein, Robert, et al.
Publicado: (2014)

1641 Evaluation of Co-Infections among Patients with Community-Associated Clostridium difficile Infection
por: Cohen, Jessica, et al.
Publicado: (2014)

527 Age-Related Changes in the Incidence of Community-Associated Clostridium Difficile Infection (CDI)
por: Faden, Howard
Publicado: (2014)

445 Epidemiology and Outcomes of Clostridium difficile Infections in Heart and Heart-lung Transplant Recipients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_57f5h1qtrb57380gpga8jlta35